PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401863
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 1401863
Malaria Vaccine Market Forecasts to 2030 - Global Analysis By Agent (Anopheles Species, Plasmodium Vivax, Plasmodium Falciparum and Other Agents), Vaccine Type, Route of Administration, Distribution Channel, End User and By Geography
According to Stratistics MRC, the Global Malaria Vaccine Market is accounted for $54.1 billion in 2023 and is expected to reach $369.5 billion by 2030 growing at a CAGR of 31.6% during the forecast period. Vaccines against malaria are medicines that offer protection against the infectious sickness carried by mosquitoes. The bite of a female Anopheles mosquito carrying the malaria virus transmits the disease, sometimes referred to as plasmodium infection. Sweating, fever, and chills are signs of this chronic illness. There are a few different ways to administer these vaccines: intramuscular, subcutaneous, and intradermal injections.
According to the WHO, there were around 229 million malaria infections and 409,000 fatalities worldwide in 2019. Malaria has primarily plagued tropical areas such as Africa, Asia, Central America, and South America.
Market Dynamics:
Driver:
High Incidence of malaria
Malaria has been a significant health concern for many years, particularly in tropical and subtropical regions. Several factors contribute to the prevalence of malaria, including climate change, drug resistance in mosquitoes and parasites, inadequate healthcare infrastructure, and socioeconomic factors. However, the rise in prevalence occurs due to changing environmental conditions or shifts in the effectiveness of existing prevention strategies. These factors contribute to the growth of the market.
Restraint:
Lack of healthcare infrastructure
People find it challenging to obtain vaccines due to restricted access to healthcare facilities resulting from inadequate infrastructure for healthcare. There aren't any clinics or hospitals in remote locations that are set up to properly store and give immunizations. Inadequate healthcare systems may also result in restricted availability of health education and immunization awareness initiatives. Low vaccination uptake and vaccine hesitancy may result from this lack of knowledge. This is the element impeding the market's expansion.
Opportunity:
Increase in the number of research and development activities
Developments in vaccination cost, safety, and effectiveness have an impact on market expansion. Public and commercial research investments have an impact on the availability of more recent and potent vaccinations. Furthermore, particularly in environments with limited resources, government and international health agency support can have a major influence on the uptake and dissemination of malaria vaccinations. These are the variables affecting the market's expansion.
Threat:
High cost of medication development
The process of developing a vaccine necessitates significant financial investments due to the rigorous research, clinical trials, and regulatory procedures involved. The sustainability of mass production and distribution is impacted if the cost of manufacturing is high. Long-term efforts to get the vaccination to people who need it most could be hampered by it. Pharmaceutical firms, governments, and organizations that sponsor these initiatives have difficulties because to the exorbitant expenses.
COVID-19 Impact:
The manufacture and delivery of medical goods, especially those required for the prevention and treatment of malaria, were hampered by the worldwide interruptions in supply chains brought about by COVID-19. This impacted the supply of diagnostic instruments, antimalarial medications, and bed nets sprayed with insecticide. Lockdowns, travel bans, and limits on face-to-face encounters all caused interruptions to clinical studies for malaria vaccinations. As a result, there has been a delay in testing, findings analysis, and gaining regulatory permissions.
The anopheles species segment is expected to be the largest during the forecast period
The anopheles species segment is expected to be the largest during the forecast period. The transmission of malaria is directly addressed by vaccination against the anopheles species. It may considerably slow the transmission of malaria by lessening the mosquito's capacity to disseminate the infection. Research on vaccinations against the malaria parasite itself is ongoing, however these efforts would be aided by the development of a vaccine against the anopheles species.
The intramuscular segment is expected to have the highest CAGR during the forecast period
The intramuscular segment is expected to have the highest CAGR during the forecast period. For medical experts, administering a vaccination intramuscularly is a rather simple process. Specialized training beyond normal injection procedures is not needed. When injected intramuscularly, certain vaccinations are more stable and maintain their effectiveness more effectively. This is particularly important for vaccinations against illnesses that are common in areas without easy access to refrigeration or healthcare services.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. Due of the disease's extensive effects, efforts have been made globally to develop and implement malaria vaccinations. Because of the decreased risk within the continent, the focus in this region has mostly been on preventive methods for visitors to malaria-prone regions rather than universal immunization. The key tactics for people visiting areas where malaria is endemic continue to be preventing mosquito bites and using antimalarial drugs.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period due to the increasing number of malarial infections, rising population and increasing government initiative for disease control. To create more potent malaria vaccines, academic institutions, pharmaceutical firms, and international health organizations have been working nonstop. In an effort to increase effectiveness, some ongoing research focuses on alternate vaccination strategies that target various phases of the malaria parasite's lifecycle.
Key players in the market:
Some of the key players in Malaria Vaccine market include Taj Pharmaceuticals Limited, Sanofi, Actiza Pharmaceutical Private Limited, Ipca Laboratories Ltd., Sumaya Biotech, Hikma Pharmaceuticals PLC, Bliss GVS Pharma Ltd., Amneal Pharmaceuticals LLC, Strides Pharma Science Limited, VLP Therapeutics, Novartis AG, Pfizer Inc., Mylan N.V., Zydus Cadila, Cipla Inc., Sun Pharmaceutical Industries Ltd., Ipca Laboratories Ltd. and GeoVax.
Key Developments:
In February 2023, Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies, has announced the acquisition of a 26.09% stake in Agatsa Software Pvt. Ltd. and a 27.39% stake in Remidio Innovative Solutions Pvt. Ltd., both of which are digital health startups.
In November 2022, Novartis and Medicines for Malaria Venture (MMV) have announced plans to advance a ganaplacide/lumefantrine- solid dispersion formulation (SDF) into a Phase III clinical trial to treat individuals with acute uncomplicated malaria caused by Plasmodium falciparum.
Agents Covered:
- Anopheles Species
- Plasmodium Vivax
- Plasmodium Falciparum
- Other Agents
Vaccine Types Covered:
- Pre-Erythrocytic Vaccine
- Erythrocytic Vaccine
- Multi-antigen Vaccine
- Other Vaccine Types
Route of Administrations Covered:
- Intramuscular
- Subcutaneous
- Intradermal
Distribution Channels Covered:
- Retail Pharmacy
- Online Pharmacy
- Hospital Pharmacy
- Other Distribution Channels
End Users Covered:
- Hospitals
- Specialty Clinics
- Homecare
- Other End Users
Regions Covered:
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- Italy
- France
- Spain
- Rest of Europe
- Asia Pacific
- Japan
- China
- India
- Australia
- New Zealand
- South Korea
- Rest of Asia Pacific
- South America
- Argentina
- Brazil
- Chile
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- UAE
- Qatar
- South Africa
- Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
- Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
- Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
- Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
- 2.1 Abstract
- 2.2 Stake Holders
- 2.3 Research Scope
- 2.4 Research Methodology
- 2.4.1 Data Mining
- 2.4.2 Data Analysis
- 2.4.3 Data Validation
- 2.4.4 Research Approach
- 2.5 Research Sources
- 2.5.1 Primary Research Sources
- 2.5.2 Secondary Research Sources
- 2.5.3 Assumptions
3 Market Trend Analysis
- 3.1 Introduction
- 3.2 Drivers
- 3.3 Restraints
- 3.4 Opportunities
- 3.5 Threats
- 3.6 End User Analysis
- 3.7 Emerging Markets
- 3.8 Impact of Covid-19
4 Porters Five Force Analysis
- 4.1 Bargaining power of suppliers
- 4.2 Bargaining power of buyers
- 4.3 Threat of substitutes
- 4.4 Threat of new entrants
- 4.5 Competitive rivalry
5 Global Malaria Vaccine Market, By Agent
- 5.1 Introduction
- 5.2 Anopheles Species
- 5.3 Plasmodium Vivax
- 5.4 Plasmodium Falciparum
- 5.5 Other Agents
6 Global Malaria Vaccine Market, By Vaccine Type
- 6.1 Introduction
- 6.2 Pre-Erythrocytic Vaccine
- 6.3 Erythrocytic Vaccine
- 6.4 Multi-antigen Vaccine
- 6.5 Other Vaccine Types
7 Global Malaria Vaccine Market, By Route of Administration
- 7.1 Introduction
- 7.2 Intramuscular
- 7.3 Subcutaneous
- 7.4 Intradermal
8 Global Malaria Vaccine Market, By Distribution Channel
- 8.1 Introduction
- 8.2 Retail Pharmacy
- 8.3 Online Pharmacy
- 8.4 Hospital Pharmacy
- 8.5 Other Distribution Channels
9 Global Malaria Vaccine Market, By End User
- 9.1 Introduction
- 9.2 Hospitals
- 9.3 Specialty Clinics
- 9.4 Homecare
- 9.5 Other End Users
10 Global Malaria Vaccine Market, By Geography
- 10.1 Introduction
- 10.2 North America
- 10.2.1 US
- 10.2.2 Canada
- 10.2.3 Mexico
- 10.3 Europe
- 10.3.1 Germany
- 10.3.2 UK
- 10.3.3 Italy
- 10.3.4 France
- 10.3.5 Spain
- 10.3.6 Rest of Europe
- 10.4 Asia Pacific
- 10.4.1 Japan
- 10.4.2 China
- 10.4.3 India
- 10.4.4 Australia
- 10.4.5 New Zealand
- 10.4.6 South Korea
- 10.4.7 Rest of Asia Pacific
- 10.5 South America
- 10.5.1 Argentina
- 10.5.2 Brazil
- 10.5.3 Chile
- 10.5.4 Rest of South America
- 10.6 Middle East & Africa
- 10.6.1 Saudi Arabia
- 10.6.2 UAE
- 10.6.3 Qatar
- 10.6.4 South Africa
- 10.6.5 Rest of Middle East & Africa
11 Key Developments
- 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
- 11.2 Acquisitions & Mergers
- 11.3 New Product Launch
- 11.4 Expansions
- 11.5 Other Key Strategies
12 Company Profiling
- 12.1 Taj Pharmaceuticals Limited
- 12.2 Sanofi
- 12.3 Actiza Pharmaceutical Private Limited
- 12.4 Ipca Laboratories Ltd.
- 12.5 Sumaya Biotech
- 12.6 Hikma Pharmaceuticals PLC
- 12.7 Bliss GVS Pharma Ltd.
- 12.8 Amneal Pharmaceuticals LLC
- 12.9 Strides Pharma Science Limited
- 12.10 VLP Therapeutics
- 12.11 Novartis AG
- 12.12 Pfizer Inc.
- 12.13 Mylan N.V.
- 12.14 Zydus Cadila
- 12.15 Cipla Inc.
- 12.16 Sun Pharmaceutical Industries Ltd.
- 12.17 Ipca Laboratories Ltd.
- 12.18 GeoVax
List of Tables
- Table 1 Global Malaria Vaccine Market Outlook, By Region (2021-2030) ($MN)
- Table 2 Global Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 3 Global Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 4 Global Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 5 Global Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 6 Global Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 7 Global Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 8 Global Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 9 Global Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 10 Global Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 11 Global Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 12 Global Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 12 Global Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 14 Global Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 15 Global Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 16 Global Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 17 Global Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 18 Global Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 19 Global Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 20 Global Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 21 Global Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 22 Global Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 23 Global Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 24 Global Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 25 Global Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 26 North America Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
- Table 27 North America Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 28 North America Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 29 North America Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 30 North America Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 31 North America Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 32 North America Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 33 North America Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 34 North America Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 35 North America Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 36 North America Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 37 North America Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 38 North America Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 39 North America Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 40 North America Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 41 North America Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 42 North America Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 43 North America Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 44 North America Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 45 North America Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 46 North America Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 47 North America Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 48 North America Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 49 North America Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 50 North America Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 51 Europe Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
- Table 52 Europe Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 53 Europe Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 54 Europe Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 55 Europe Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 56 Europe Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 57 Europe Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 58 Europe Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 59 Europe Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 60 Europe Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 61 Europe Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 62 Europe Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 63 Europe Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 64 Europe Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 65 Europe Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 66 Europe Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 67 Europe Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 68 Europe Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 69 Europe Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 70 Europe Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 71 Europe Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 72 Europe Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 73 Europe Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 74 Europe Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 75 Europe Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 76 Asia Pacific Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
- Table 77 Asia Pacific Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 78 Asia Pacific Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 79 Asia Pacific Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 80 Asia Pacific Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 81 Asia Pacific Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 82 Asia Pacific Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 83 Asia Pacific Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 84 Asia Pacific Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 85 Asia Pacific Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 86 Asia Pacific Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 87 Asia Pacific Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 88 Asia Pacific Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 89 Asia Pacific Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 90 Asia Pacific Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 91 Asia Pacific Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 92 Asia Pacific Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 93 Asia Pacific Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 94 Asia Pacific Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 95 Asia Pacific Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 96 Asia Pacific Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 97 Asia Pacific Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 98 Asia Pacific Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 99 Asia Pacific Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 100 Asia Pacific Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 101 South America Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
- Table 102 South America Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 103 South America Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 104 South America Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 105 South America Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 106 South America Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 107 South America Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 108 South America Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 109 South America Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 110 South America Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 111 South America Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 112 South America Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 113 South America Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 114 South America Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 115 South America Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 116 South America Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 117 South America Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 118 South America Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 119 South America Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 120 South America Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 121 South America Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 122 South America Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 123 South America Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 124 South America Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 125 South America Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
- Table 126 Middle East & Africa Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
- Table 127 Middle East & Africa Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
- Table 128 Middle East & Africa Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
- Table 129 Middle East & Africa Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
- Table 130 Middle East & Africa Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
- Table 131 Middle East & Africa Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
- Table 132 Middle East & Africa Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
- Table 133 Middle East & Africa Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
- Table 134 Middle East & Africa Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
- Table 135 Middle East & Africa Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
- Table 136 Middle East & Africa Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
- Table 137 Middle East & Africa Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
- Table 138 Middle East & Africa Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
- Table 139 Middle East & Africa Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
- Table 140 Middle East & Africa Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
- Table 141 Middle East & Africa Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
- Table 142 Middle East & Africa Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
- Table 143 Middle East & Africa Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
- Table 144 Middle East & Africa Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
- Table 145 Middle East & Africa Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
- Table 146 Middle East & Africa Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
- Table 147 Middle East & Africa Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
- Table 148 Middle East & Africa Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
- Table 149 Middle East & Africa Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
- Table 150 Middle East & Africa Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
